clorgyline has been researched along with Hypertrophy, Right Ventricular in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clorgyline treatment reduced RV afterload and pulmonary vascular remodeling in SuHx rats through reduced pulmonary vascular proliferation and oxidative stress." | 1.62 | Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension. ( Andersen, A; Andersen, S; Axelsen, JB; Bogaard, HJ; da Silva Goncalves Bos, D; de Man, FS; Gomez-Puerto, MC; Goumans, MJ; Kurakula, K; Pan, X; Peters, EL; Schalij, I; Schiepers, REJ; Sun, XQ; Szulcek, R; van der Laarse, WJ; Vonk Noordegraaf, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, XQ | 1 |
| Peters, EL | 1 |
| Schalij, I | 1 |
| Axelsen, JB | 1 |
| Andersen, S | 1 |
| Kurakula, K | 1 |
| Gomez-Puerto, MC | 1 |
| Szulcek, R | 1 |
| Pan, X | 1 |
| da Silva Goncalves Bos, D | 1 |
| Schiepers, REJ | 1 |
| Andersen, A | 1 |
| Goumans, MJ | 1 |
| Vonk Noordegraaf, A | 1 |
| van der Laarse, WJ | 1 |
| de Man, FS | 1 |
| Bogaard, HJ | 1 |
1 other study available for clorgyline and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
Topics: Animals; Clorgyline; Disease Models, Animal; Disease Progression; Heart Ventricles; Humans; Hypertro | 2021 |